Moonlake Immunotherapeutics

MLTX·NASDAQ·$18.23Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202502/25/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report09/30/26 8-KCurrent report08/10/26 8-KCurrent report07/15/26 8-KCurrent report06/25/26 8-KCurrent report06/22/26

Prospectuses and Registrations

S-3ASRAutomatic shelf registration08/10/26 S-8Registration of securities for employees08/10/26 424B5Prospectus supplement06/24/26 424B5Prospectus supplement06/22/26 424B5Prospectus supplement11/05/25

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/21/26 DEF 14ADefinitive proxy04/22/25 DEFA14AAdditional proxy materials04/22/25 DEF 14ADefinitive proxy04/24/24

Ownership

SC 13GBeneficial ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction07/29/26 Form 4Insider transaction07/23/26

Other

ARSAnnual report to shareholders04/21/26 ARSAnnual report to shareholders04/22/25 UPLOADLetter from the SEC05/13/24 CORRESPCorrespondence with the SEC05/07/24 UPLOADLetter from the SEC04/29/24